Earnings History Data for Atara Biotherapeutics (ATRA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Atara Biotherapeutics

Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. The company's lead programs are focused on myostatin and activin, members of the TGF-beta family of proteins that have demonstrated the potential to have therapeutic benefit in a number of clinical indications. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. Atara Biotherapeutics, Inc. is headquartered in Brisbane, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-08-2024 AH ATRA Atara Biotherapeutics 37.00 -3.10 -1.25 0.00 Atara Biotherapeutics GAAP EPS of -$3.10 misses by $1.54, revenue of $28.64M misses by $8.45M
[8/12/2024 5:34 PM]
8.10 0.33 
(4.25%)
0.0 0.0 
(0.00%)
4.97 - 52.25 50,496 50,000 0
09-05-2024 AH ATRA Atara Biotherapeutics 73.00 -0.23 -0.37 0.00 Atara Biotherapeutics GAAP EPS of -$0.23 beats by $0.02, revenue of $27.36M beats by $2.67M
[5/9/2024 5:26 PM]
0.5370 -0.01 
(-1.61%)
0.57 0.02 
(4.43%)
0.20 - 2.54 1,804,936 1,230,000 147,849
28-03-2024 PM ATRA Atara Biotherapeutics, Inc. 68.28 -0.56 -0.61 -0.72 Atara Biotherapeutics GAAP EPS of -$0.56 misses by $0.03, revenue of $4.25M misses by $10.01M
[3/28/2024 8:43 AM]
0.7072 0.01 
(1.03%)
0.67 -0.03 
(-3.73%)
0.20 - 3.08 1,096,273 1,420,000 25,384
01-11-2023 PM ATRA Atara Biotherapeutics 130.00 -0.66 -0.63 0.00 1.25 -0.04 
(-2.71%)
1.31 0.02 
(1.55%)
1.24 - 5.64 1,665,270 1,040,000 56,858
08-08-2023 AH ATRA Atara Biotherapeutics, Inc. 225.34 -0.68 -0.64 -0.31 Atara Biotherapeutics GAAP EPS of -$0.68 misses by $0.01, revenue of $0.96M misses by $2.81M
[8/8/2023 4:21 PM]
1.88 -0.40 
(-17.40%)
2.25 -0.02 
(-0.88%)
1.45 - 5.94 1,182,594 1,350,000 13,406
08-05-2023 AH 4:00 PM ET
(May 8)
ATRA Atara Biotherapeutics, Inc. 265.73 -0.72 -0.40 -0.87 Atara Biotherapeutics GAAP EPS of -$0.72 misses by $0.36, revenue of $1.23M misses by $29.45M
[5/8/2023 5:07 PM]
2.44 -0.54 
(-18.01%)
2.94 -0.03 
(-1.01%)
2.19 - 9.34 3,054,222 1,280,000 857
08-02-2023 AH 4:00 PM ET
(Feb 8)
ATRA Atara Biotherapeutics, Inc. 490.52 -0.72 -0.46 -0.96 Atara Biotherapeutics GAAP EPS of -$0.72 misses by $0.30, revenue of $0.22M misses by $39.45M
[2/8/2023 4:02 PM]
4.76 -0.28 
(-5.56%)
4.80 -0.24 
(-4.76%)
2.83 - 16.07 1,087,059 900,000 8,044
08-11-2022 AH 4:00 PM ET
(Nov 8)
ATRA Atara Biotherapeutics, Inc. 438.78 -0.82 -0.78 -0.90 Atara Biotherapeutics GAAP EPS of -$0.82 misses by $0.03, revenue of $4.46M beats by $0.72M
[11/8/2022 4:03 PM]
3.88 -1.02 
(-20.71%)
4.68 -0.22 
(-4.49%)
2.83 - 18.85 1,118,662 1,120,000 2,055
08-08-2022 AH 4:00 PM ET
(Aug 8)
ATRA Atara Biotherapeutics, Inc. 300.77 -0.31 -0.91 -0.91 Atara Biotherapeutics GAAP EPS of $0.18 beats by $1.14, revenue of $51.58M beats by $45.05M
[8/8/2022 4:19 PM]
4.69 1.06 
(29.20%)
3.85 0.22 
(6.06%)
2.83 - 20.04 13,870,294 2,230,000 85,698
05-05-2022 AH 4:05 PM ET
(May 5)
ATRA Atara Biotherapeutics, Inc. 646.10 -0.87 -0.98 -0.86 Atara Biotherapeutics GAAP EPS of -$0.87 beats by $0.14, revenue of $7.31M beats by $2.98M
[5/5/2022 4:39 PM]
6.92 0.10 
(1.47%)
6.82 0.0 
(0.00%)
6.31 - 20.04 693,701 890,000 169,778
28-02-2022 AH 4:00 PM ET
(Feb 28)
ATRA Atara Biotherapeutics, Inc. 1,190 -0.96 -0.60 -0.95 Atara Biotherapeutics GAAP EPS of -$0.96 misses by $0.37, revenue of $7.55M misses by $27.59M
[2/28/2022 4:12 PM]
10.15 -2.70 
(-21.01%)
12.68 -0.17 
(-1.32%)
9.93 - 20.04 2,074,105 810,000 1,370
04-11-2021 PM 7:30 AM ET
(Nov 4)
ATRA Atara Biotherapeutics, Inc. 1,400 -0.90 -0.92 -0.92 Atara Biotherapeutics EPS beats by $0.06, beats on revenue
[11/4/2021 7:35 AM]
19.89 1.14 
(6.08%)
19.89 0.0 
(0.00%)
11.81 - 28.20 948,631 650,000 9,491
09-08-2021 AH 4:00 PM ET
(Aug 9)
ATRA Atara Biotherapeutics, Inc. 1,080 -0.91 -0.88 -1.14 Atara Biotherapeutics EPS beats by $0.02, misses on revenue
[8/9/2021 4:03 PM]
12.75 0.26 
(2.08%)
13.05 0.56 
(4.48%)
11.33 - 28.20 925,166 550,000 4,162
04-05-2021 AH 4:05 PM ET
(May 4)
ATRA Atara Biotherapeutics, Inc. 1,220 -0.86 -0.93 -1.20 Atara Biotherapeutics EPS beats by $0.08, beats on revenue
[5/4/2021 4:27 PM]
13.51 -0.14 
(-1.03%)
14.30 0.65 
(4.76%)
8.39 - 28.20 695,339 1,120,000 7,230
01-03-2021 AH 4:00 PM ET
(Mar 1)
ATRA Atara Biotherapeutics, Inc. 1,380 -0.95 -0.73 -1.36 Atara Biotherapeutics EPS misses by $0.17
[3/1/2021 4:11 PM]
17.07 -0.04 
(-0.20%)
16.70 -0.40 
(-2.37%)
4.52 - 28.20 1,415,410 679,291 1,055
09-11-2020 AH 4:00 PM ET
(Nov 9)
ATRA Atara Biotherapeutics, Inc. 1,030 -0.92 -1.10 -1.31 Atara Biotherapeutics EPS beats by $0.16
[11/9/2020 4:02 PM]
15.55 1.15 
(7.99%)
14.88 0.48 
(3.33%)
4.52 - 19.36 1,417,378 534,695 1,191
05-08-2020 AH 4:00 PM ET
(Aug 5)
ATRA Atara Biotherapeutics, Inc. 915.75 -1.14 -1.21 -1.60 Atara Biotherapeutics EPS in-line
[8/5/2020 4:11 PM]
12.74 0.03 
(0.24%)
13.50 0.79 
(6.22%)
4.52 - 19.36 401,018 778,283 6,623
06-05-2020 AH ATRA Atara Biotherapeutics, Inc. 518.78 -1.20 -1.36 -1.44 0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0